
    
      To evaluate the therapeutic equivalence and safety of Test formulation and marketed Reference
      Listed Drug (RLD).

      To demonstrate the superiority of efficacy of the Test and Reference products over the
      placebo control in the treatment.

      To compare the safety of Test, Reference and Placebo treatments.
    
  